Provided by Tiger Fintech (Singapore) Pte. Ltd.

InflaRx N.V.

1.16
+0.02001.75%
Post-market: 1.160.00000.00%19:24 EDT
Volume:320.50K
Turnover:373.72K
Market Cap:78.42M
PE:-1.43
High:1.21
Open:1.15
Low:1.10
Close:1.14
Loading ...

Sector Update: Health Care Stocks Flat to Higher Premarket Friday

MT Newswires Live
·
14 Feb

InflaRx Slumps Premarket After Pricing $30 Million Offering of Ordinary Shares, Pre-Funded Warrants

MT Newswires Live
·
14 Feb

Inflarx Says Pricing Of Underwritten Public Offering Of 8.25 Mln Ordinary Shares At $2.00 Per Ordinary Share

Reuters
·
14 Feb

InflaRx announces ordinary shares and warrants offering, no amount given

TIPRANKS
·
14 Feb

Adlai Nortye And 2 Other Penny Stocks On US Exchanges To Watch

Simply Wall St.
·
04 Feb

InflaRx Stock Rises 8% on Conditional EC Nod for COVID-19 Drug

Zacks
·
16 Jan

InflaRx Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Jan

InflaRx Gets Marketing Approval for COVID-19 Therapy in Europe

MT Newswires Live
·
16 Jan

InflaRx announces EC grants marketing authorization to Gohibic for ARDS

TIPRANKS
·
16 Jan

InflaRx Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Dec 2024

InflaRx announces first patient dosed in 2a study of CSU, HS

TIPRANKS
·
20 Dec 2024

Is InflaRx N.V. (IFRX) the Best German Stock to Buy Now?

Insider Monkey
·
20 Nov 2024

InflaRx Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Nov 2024

LifeSci Capital Reaffirms Their Hold Rating on InflaRx (IFRX)

TIPRANKS
·
16 Nov 2024

InflaRx Says Severe Covid Drug Gets EU Panel's Positive Opinion; Shares Rise Pre-Bell

MT Newswires Live
·
15 Nov 2024

InflaRx Gets EMA Nod for COVID-19 Treatment

TIPRANKS
·
15 Nov 2024

InflaRx Shares Rise 12% After Regulators Favor Authorization of Gohibic

Dow Jones
·
15 Nov 2024

InflaRx receives positive CHMP opinion for GOHIBIC for SARS-CoV-2-induced ARDS

TIPRANKS
·
15 Nov 2024

Prenetics Global And 2 Other US Penny Stocks To Watch

Simply Wall St.
·
14 Nov 2024

InflaRx Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Nov 2024